Ford expands its GCC footprint with a new Coimbatore centre

India, Ford Motor’s global capability center, opened a new office in Coimbatore. Spread over 82,000 sqft, with seating for ...

The new tastemakers are cutlery designers

The design writer and collector Dung Ngo owns more than 10,000 pieces of cutlery. Now, he’s asked artists to imagine what ...
Scientific Research Publishing

Specificities of Tropical Wood Drying Prior to Processing Stages: How to Choose a Dryer in the City of Mbalmayo, Cameroon ()

University Institute of Technology of Wood, University of Yaoundé I, Mbalmayo, Cameroon. 2 ISABEE of University of Ebolowa, ...

Iran targeted civilians as tactic of war, new report pushes IRGC accountability, JIJ attorney says

Adv. Uri Morad said that Iran’s missile campaign targeted civilians as a tactic of war, and argued that senior Iranian ...
MUO on MSN

Excel’s MOD function is weird, but now I use it everywhere

The more I learned MOD, the more excuses I found to use it.
It's Nice That

How Freitag keeps its cool: A look inside the brand’s less-than-conventional approach to creative campaigns

The cult favourite Swiss brand is built on inventive ideas and a healthy dose of Dada-esque humour. To find out more about why its marketing has never missed, we talk to creative director, Thomas ...
The LancetOpinion

Asthma diagnosis in adults and children: challenges, future directions, and a call to action

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

Want to leverage wearable tech like a World Cup athlete? Here are the metrics to track

Millions of people around the world wear smart rings and fitness trackers to keep tabs on their sleep, workouts, heart rate ...

Otsuka Reports Positive Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Prevented Progression to Kidney Failure and Improved Kidney ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...